Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

Let’s face it: flawless skin and confidence go hand in hand. Whether you’re dreaming of a radiant complexion or tackling more ...

Melasma, commonly known as "masked face," causes dark patches on the skin due to hormonal changes, sun exposure, and genetics ...

Melasma is a common skin condition that affects ... them using liquid nitrogen therapy (cryotherapy). Standard at-home treatment for actinic keratosis includes topical medication.

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

Melasma, a common hyperpigmentation disorder, often presents as dark, irregular patches on the face and affects quality of life. While hydroquinone has been the standard treatment for decades, ...

The objectives of this study were the assessment of safety and efficacy of topical Silymain (SM) cream in a double-blind placebo controlled study for treatment of melasma patients. Methods ...

Disease prevention is a procedure through which individuals, particularly those with risk factors for a disease, are treated in order to prevent a disease from occurring. Treatment normally begins ...

Identifying these factors can help open the door to treatment and prevention options. Multiple sclerosis (MS) is a disease of the central nervous system. More than 2.8 million people worldwide ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...